SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001062993-17-003221
Filing Date
2017-07-14
Accepted
2017-07-13 17:38:25
Documents
71
Period of Report
2017-05-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q form10q.htm 10-Q 403605
2 EXHIBIT 31.1 exhibit31-1.htm EX-31.1 7129
3 EXHIBIT 31.2 exhibit31-2.htm EX-31.2 7302
4 EXHIBIT 32.1 exhibit32-1.htm EX-32.1 2830
5 EXHIBIT 32.2 exhibit32-2.htm EX-32.2 3004
  Complete submission text file 0001062993-17-003221.txt   4454306

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE lxrp-20170531.xml EX-101.INS 420754
7 XBRL SCHEMA FILE lxrp-20170531.xsd EX-101.SCH 152316
8 XBRL CALCULATION FILE lxrp-20170531_cal.xml EX-101.CAL 45637
9 XBRL DEFINITION FILE lxrp-20170531_def.xml EX-101.DEF 431555
10 XBRL LABEL FILE lxrp-20170531_lab.xml EX-101.LAB 950066
11 XBRL PRESENTATION FILE lxrp-20170531_pre.xml EX-101.PRE 482801
Mailing Address 156 VALLEYVIEW ROAD KELOWNA A1 V1X 3M4
Business Address 156 VALLEYVIEW ROAD KELOWNA A1 V1X 3M4 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-52138 | Film No.: 17964203
SIC: 1000 Metal Mining